Operating Lease, Right-of-Use Asset of TITAN PHARMACEUTICALS INC from 31 Dec 2018 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TITAN PHARMACEUTICALS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Mar 2024.
  • TITAN PHARMACEUTICALS INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $32,000, a 79% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TITAN PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $32,000 -$122,000 -79% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $63,000 -$120,000 -66% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $94,000 -$118,000 -56% 30 Sep 2023 10-K 01 Apr 2024 2023 FY
Q2 2023 $124,000 -$117,000 -49% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $154,000 -$115,000 -43% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $183,000 -$114,000 -38% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $212,000 -$112,000 -35% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $241,000 -$112,000 -32% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $269,000 +$197,000 +274% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $297,000 +$156,000 +111% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $324,000 +$116,000 +56% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $353,000 +$80,000 +29% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $72,000 -$264,000 -79% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $141,000 -$256,000 -64% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 $208,000 -$248,000 -54% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $273,000 -$241,000 -47% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $336,000 -$233,000 -41% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $397,000 +$397,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $456,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $514,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $569,000 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 30 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.